Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

XBI SPDR S&P Biotech ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$10.3Bfund assets
+19.6%return, YTD
—return, 1 year
−$8Mnet flow, 1 month
+$675Mnet flow, 1 year
30.3%realized volatility, 1y
-14.9%worst drawdown, 1y
Top ten holdings
1MRNA MODERNA2.47%
2BIIB BIOGEN1.80%
3AMGN AMGEN1.79%
4REGN REGENERON PHARMACEUTICALS1.78%
5ABBV ABBVIE1.76%
6UTHR UNITED THERAPEUTICS1.75%
7GILD GILEAD SCIENCES1.74%
8EXEL EXELIXIS1.78%
9TGTX TG THERAPEUTICS1.77%
10SYRE SPYRE THERAPEUTICS INC1.80%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.